<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-103342</identifier>
<setSpec>0211-6995</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Membranous glomerulonephritis, psoriasis and etanercept. A chance or causal association?</dc:title>
<dc:description xml:lang="en">Psoriasis is a cutaneous disease with systemic involvement. Tisular damage is consider to be immunomediated, and actually is being effectively treated with Etanercept. Kidney damage of this patological condition is not completely clarified in the literature. We present a case of Membranous Nephropathy with C1q deposits that subsequently developed psoriasis. In this article we make a review of a possible association between these diseases and the respose to that biological molecule (AU)</dc:description>
<dc:creator>Úbeda-Aranda, Isabel</dc:creator>
<dc:creator>Valga-Amado, Francisco</dc:creator>
<dc:creator>Monzón-Vázquez, Tania</dc:creator>
<dc:creator>Florit, Enrique A</dc:creator>
<dc:creator>Rodríguez-Cubillo, Beatriz</dc:creator>
<dc:creator>Delgado-Conde, Pablo</dc:creator>
<dc:creator>Flor Merino, José C. de la</dc:creator>
<dc:creator>Barrientos-Guzmán, Alberto</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La psoriasis es una enfermedad cutánea con afectación sistémica, cuyo daño tisular se considera inmunomediado y que en la actualidad se trata eficazmente con etanercept. El daño renal de esta patología no está completamente aclarado en la literatura. Presentamos un caso de glomerulonefritis membranosa con depósitos de C1q que posteriormente desarrolló psoriasis. En este artículo hacemos una revisión de la posible asociación entre estas patologías y la respuesta a esta molécula biológica (AU)</dc:description>
<dc:source>Nefrologia;32(2): 228-232, mar.-abr. 2012. ilus</dc:source>
<dc:identifier>ibc-103342</dc:identifier>
<dc:title xml:lang="es">Glomerulonefritis membranosa, psoriasis y etanercept. ¿Asociación casual o causal?</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d38737^s22006</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d23656^s22012</dc:subject>
<dc:subject>^d7335^s22012</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d12002^s22012</dc:subject>
<dc:type>article</dc:type>
<dc:date>201204</dc:date>
</metadata>
</record>
</ibecs-document>
